# Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-of-hcc-with-pravastatin-octreotide-or-gemcitabine-a-critical/

## Facts

| Field | Value |
| --- | --- |
| Author Names | C. Lersch,Renate Schmelz,Joris I. Erdmann,Regina Hollweck,Ewert Schulte‐Frohlinde,Florian Eckel,Michael Nader,Schusdziarra |
| Citations | 39 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2418412985 |
| PMID | 15239254 |
| Type | article |
| Year | 2004 |

## Paper authors

- [Renate Schmelz](https://scholariq.org/researchers/renate-schmelz/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

## Paper topics

- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Adrenal and Paraganglionic Tumors](https://scholariq.org/topics/adrenal-and-paraganglionic-tumors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.